Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Additional Listing

17th Dec 2013 09:48

RNS Number : 7248V
ABCAM Plc
17 December 2013
 



For immediate release

17 December 2013

ABCAM PLC

("Abcam" or "the Company")

Additional Listing

Application has been made to AIM for the block listing of 1,750,000 ordinary shares of 0.2p each in the Company. These shares will be issued as appropriate, over time, in connection with the following option schemes:

 

1,000,000 under the Abcam 2005 Share Option Scheme

350,000 under the Abcam plc Share Incentive Plan

400,000 under the Abcam plc Annual Bonus Plan

 

When issued, the shares will rank pari passu in all respects with the existing shares in issue. It is expected that the block listing will become effective on 18 December 2013.

 

 

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Jeff Iliffe, Chief Financial Officer

 

Numis Securities - Nominated Adviser & Joint Broker

+ 44 (0) 20 7260 1000

Michael Meade - Nominated Adviser

James Black - Corporate Broking

 

Peel Hunt LLP - Joint Broker

+ 44 (0) 20 7418 8900

Andy Crossley - Corporate Broking

 

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles

 

Notes for editors:

About Abcam plc

 

Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level to improve the understanding of health and disease.

Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 127,000 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported with detailed, up-to-date and unbiased data on our website.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices and ships to over 100 countries. The Company was founded in 1998 and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).

To find out more, please visit www.abcam.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISFMMMZLNGGFZG

Related Shares:

ABC.L
FTSE 100 Latest
Value8,809.74
Change53.53